MedTrace Logo

PICC-ports Versus Chest - Ports for Long Term Chemotherapy Deliverance in Oncology Patients

NCT06541301 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 852

Last updated 2024-11-19

No results posted yet for this study

Summary

Central venous access devices are extensively used in oncology patients. The current standard is represented by devices inserted by direct ultrasound guided cannulation of deep veins of supra/infraclavicular area with a reservoir placed in a subcutaneous pocket of the upper chest wall ("chest-ports"). More recently, PICC (Peripherally Inserted Central Catheters)-ports have been proposed as an alternative to chest-ports.

Aim of this study is to demonstrate the non-inferiority of PICC ports compared to thoracic ports in terms of efficacy and safety.

Conditions

Interventions

DEVICE

PICC-port

Implantation of a PICC-port device by a dedicated PICC team member following predefined evidence-based international guidelines and protocols

DEVICE

Chest-port

Implantation of a Chest-port device by expert physicians or certified expert nurses, following predefined evidence-based international guidelines and protocols

Sponsors & Collaborators

  • European Institute of Oncology

    lead OTHER

Principal Investigators

  • Roberto Biffi, MD · European Istitute of Oncology

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-31
Primary Completion
2026-02-28
Completion
2026-02-28

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06541301 on ClinicalTrials.gov